Allergic rhinitis
Trovati 7 articoli
- Montelukast and possible risk of suicide
- The FDA ( Food and Drug Administration ) is investigating a possible association between the use of Singulair ( Montelukast ) and behavior/mood changes, suicidality ( suicidal thinking and behavior ) and suicide. Singulair is a medicine in the drug class known as leukotriene receptor antagoni... (Leggi Articolo)
- Singulair: possible association with behavior/mood changes, suicidality and suicide
- The FDA ( Food and Drug Adminsitration ) is investigating a possible association between the use of Singulair ( Montelukast ) and behavior/mood changes, suicidality ( suicidal thinking and behavior ) and suicide. Singulair is a medicine in the drug class known as leukotriene receptor antagon... (Leggi Articolo)
- Singulair for perennial allergic rhinitis, FDA approved
- The Fda ( Food and Drug Administration ) has approved Singulair ( Montelukast ) for the relief of symptoms of perennial allergic rhinitis ( PAR ), or indoor allergies, in adults and children six months of age and older. A convenient once-a-day tablet, Singulair has been proven to help relieve ... (Leggi Articolo)
- Products derived from bees: serious adverse reactions
- Substances derived from bees include bee pollen, royal jelly and propolis. Bee pollen can come from a variety of plants and may include pollen to which people are commonly allergic ( e.g., ragweed pollen ). Royal jelly consists of the secretions of the hypopharyngeal and mandibular glands of wo... (Leggi Articolo)
- TLR4 agonist for patients with allergic rhinitis
- Preliminary results of the clinical trial of CRX-675, a toll-like receptor 4 ( TLR4 ) agonist, in subjects allergic to ragweed showed that the drug is safe. The study was a randomized, blinded, placebo-controlled trial of single doses of CRX-675 given intranasally prior to intranasal challeng... (Leggi Articolo)
- FDA approves Asmanex for once-daily treatment of asthma
- The FDA ( Food and Drug Administration ) has approved the use of Asmanex Twisthaler 220 mcg ( Mometasone furoate inhalation powder ) for the first-line maintenance treatment of asthma as preventive therapy in patients 12 years of age and older. Clinical studies with Asmanex have shown improv... (Leggi Articolo)
- New treatment guidelines for pregnant women with asthma
- The National Asthma Education and Prevention Program (NAEPP) has issued the first new guidelines for managing asthma during pregnancy. The report reflects new medications that have emerged and updates treatment recommendations for pregnant women with asthma based on a systematic review of data o... (Leggi Articolo)
